DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,901 | +3.8% | 309,958 | +0.4% | 0.42% | +7.2% |
| Q2 2023 | $74,113 | -3.9% | 308,806 | +1.0% | 0.39% | -11.4% |
| Q1 2023 | $77,099 | -3.6% | 305,898 | +1.5% | 0.44% | -10.1% |
| Q4 2022 | $79,965 | -99.9% | 301,276 | +4.0% | 0.49% | -1.6% |
| Q3 2022 | $74,820,000 | +2.3% | 289,674 | +0.4% | 0.50% | +7.1% |
| Q2 2022 | $73,147,000 | -10.9% | 288,526 | +3.1% | 0.46% | +1.5% |
| Q1 2022 | $82,121,000 | -10.3% | 279,960 | +0.6% | 0.46% | -6.0% |
| Q4 2021 | $91,601,000 | +8.6% | 278,414 | +0.5% | 0.48% | -0.8% |
| Q3 2021 | $84,368,000 | +13.8% | 277,124 | +0.3% | 0.49% | +13.5% |
| Q2 2021 | $74,165,000 | +21.4% | 276,364 | +1.8% | 0.43% | +12.0% |
| Q1 2021 | $61,085,000 | +2.6% | 271,394 | +1.2% | 0.38% | -3.0% |
| Q4 2020 | $59,546,000 | +4.0% | 268,054 | +0.8% | 0.40% | -8.5% |
| Q3 2020 | $57,270,000 | +22.9% | 265,964 | +0.9% | 0.43% | +12.5% |
| Q2 2020 | $46,592,000 | +13.4% | 263,484 | -11.2% | 0.38% | +5.5% |
| Q1 2020 | $41,072,000 | -2.8% | 296,742 | +7.8% | 0.36% | +4.3% |
| Q4 2019 | $42,267,000 | +3.9% | 275,392 | -2.2% | 0.35% | -4.9% |
| Q3 2019 | $40,676,000 | -28.6% | 281,632 | -29.3% | 0.37% | +5.4% |
| Q2 2019 | $56,954,000 | +9.9% | 398,502 | +1.6% | 0.35% | +5.1% |
| Q1 2019 | $51,805,000 | +31.6% | 392,402 | +2.8% | 0.33% | +15.7% |
| Q4 2018 | $39,360,000 | -3.8% | 381,692 | +1.4% | 0.29% | +11.2% |
| Q3 2018 | $40,906,000 | +62.8% | 376,458 | +47.9% | 0.26% | -0.8% |
| Q2 2018 | $25,125,000 | +169.6% | 254,615 | +167.5% | 0.26% | +7.0% |
| Q1 2018 | $9,318,000 | – | 95,173 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |